Oscar Health, Inc.

Day range

$30.78 – $32.35

Open

$31.00

Prev close

$30.99

Volume

1.86M

Market cap

$9.56B

Shares out

273.47M

P/E

17.37

P/S

0.63

P/B

4.66

P/FCF

2.18

ROE

26.8%

ROA

4.9%

Debt/Equity

0.21

Div yield

0.00%

As of Oct 23, 2026

• Guidance issuance or updateSep 16, 2026

  The Company will also discuss its financial performance and outlook, including the following improvements to its full year 2026 guidance: Medical Loss Ratio between 81.0% and 82.0% (an improvement of 50 basis points from its previous expectation of 81.5% to 82.5%); and Earnings from Operations between $600 million and $800 million (an increase of $100 million from its previous expectation of $500 million to $700 million). In addition, the Company will reaffirm the following full year 2026 guidance: Total Revenue between $18.7 billion and $19.0 billion; and SG&A Expense Ratio between 15.6% and 16.1%.

• Annual meeting resultsJun 9, 2026

  On June 4, 2026, Oscar Health, Inc. (the "Company") held its 2026 Annual Meeting of Stockholders (the "Annual Meeting")... The stockholders of the Company voted as follows at the Annual Meeting: Proposal 1 – Election of eight director nominees to serve until the 2027 Annual Meeting... Proposal 2 – Advisory vote to approve named executive officer compensation... Proposal 3 – Ratification of appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026... Based on the foregoing votes, the eight director nominees were elected, and Items 2 and 3 were approved.

• Guidance issuance or updateJun 8, 2026

  At the Conference, the Company plans to provide a business update and reaffirm its full year 2026 guidance, as previously provided in its financial results press release dated February 10, 2026.

• Executive officer departureJun 2, 2026

  Mario Schlosser entered into an amended and restated employment agreement, effective as of June 1, 2026, in connection with Mr. Schlosser's transition from President of Technology and Chief Technology Officer of the Company to Co-Founder & Advisor to the CEO.

• Guidance issuance or updateApr 21, 2026

  Oscar Health, Inc. (the "Company"), in advance of its upcoming participation in the Medicarians 2026 conference on April 21, 2026, is reaffirming the full year 2026 guidance that it provided in its financial results press release for the fourth quarter and full year 2025 dated February 10, 2026.

Days to cover

2.7

Short interest

16.45M

Avg volume

6.14M

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Best Growth Stocks to Buy for October 26th
  positiveZacks Investment Research· Oct 26, 2026
• Why Oscar Health, Inc. (OSCR) Dipped More Than Broader Market Today
  positiveZacks Investment Research· Oct 23, 2026
• Oscar Health vs. Molina: Which Healthcare Stock Is a Better Buy?
  positiveZacks Investment Research· Oct 16, 2026
• Are Finance Stocks Lagging ASX Limited - Unsponsored ADR (ASXFY) This Year?
  positiveZacks Investment Research· Oct 16, 2026
• Zacks Investment Ideas feature highlights: CoreWeave, Cinemark, Oscar Health and Heico
  positiveZacks Investment Research· Oct 16, 2026